1

Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)

wurerewfc4kmwh
Background: Traditionally believed to be an integral part of multiple myeloma (MM) treatment. the role of hematopoietic stem-cell transplantation (HSCT) is being challenged. As such. we sought to evaluate the impact of HSCT in the era of novel agents. https://www.lightspeedlovers.shop/product-category/bondage-collars/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story